We are live on ! Find out more
NTBL

Notable Labs, Ltd. Ordinary Shares

Delisted

NTBL was delisted on the 22nd of October, 2024.

18 hedge funds and large institutions have $2.26M invested in Notable Labs, Ltd. Ordinary Shares in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,350% more call options, than puts

Call options by funds: $116K | Put options by funds: $8K

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

5% less funds holding

Funds holding: 1918 (-1)

10% less capital invested

Capital invested by funds: $2.51M → $2.26M (-$250K)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
6
Closed
1
Calls
$116K
Puts
$8K
Net Calls
+$108K
Net Calls Change
-$7K

NTBL Hedge Fund Activity: Q3 2019 in Review

18 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Notable Labs, Ltd. Ordinary Shares (NTBL) for Q3 2019, worth a combined $2.26M — down 9.9% from $2.51M a quarter earlier.

Fund positioning in NTBL was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 6 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $31.6K. The largest seller was Sabby Management, cutting an estimated $151K.

  • 18 institutional investors held Notable Labs, Ltd. Ordinary Shares (NTBL) as of Q3 2019, down from 19 in Q2 2019.
  • Funds reported $2.26M of Notable Labs, Ltd. Ordinary Shares stock for Q3 2019, down 9.9% quarter-over-quarter.
  • 1 fund opened new Notable Labs, Ltd. Ordinary Shares positions in Q3 2019 and 1 closed out, a net change of 0 holders.
  • The largest Notable Labs, Ltd. Ordinary Shares buyer in Q3 2019 was Morgan Stanley, an estimated $31.6K added.
  • The largest Notable Labs, Ltd. Ordinary Shares seller in Q3 2019 was Sabby Management, an estimated $151K sold.

Based on aggregated 13F filings for Q3 2019.